2013
DOI: 10.1016/j.bbr.2013.01.033
|View full text |Cite
|
Sign up to set email alerts
|

Is behavioral sensitization to 3,4-methylenedioxymethamphetamine (MDMA) mediated in part by cholinergic receptors?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
5
1

Year Published

2014
2014
2017
2017

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 28 publications
2
5
1
Order By: Relevance
“…It is noteworthy that the failure to observe a concomitant increase in the number of forward locomotor counts contrasts with previously reported increases in forward locomotion, as measured by locomotor activity counts, that became sensitised following repeated intermittent exposure to ± MDMA (Ball et al, 2006;Lettfuss et al, 2013;Spanos and Yamamoto, 1989;Kalivas et al, 1998) including data from our laboratory (Bradbury et al, 2012). We previously reported that repeated daily injections of racemic MDMA (10.0 mg/kg, IP × 5 days) increased the number of ambulatory counts in response to 10.0 mg/kg MDMA and shifted the dose-effect curve for this response to the left when measured 2 days following the last experimenter-administered exposure to MDMA (Bradbury et al, 2012).…”
Section: Discussioncontrasting
confidence: 79%
See 1 more Smart Citation
“…It is noteworthy that the failure to observe a concomitant increase in the number of forward locomotor counts contrasts with previously reported increases in forward locomotion, as measured by locomotor activity counts, that became sensitised following repeated intermittent exposure to ± MDMA (Ball et al, 2006;Lettfuss et al, 2013;Spanos and Yamamoto, 1989;Kalivas et al, 1998) including data from our laboratory (Bradbury et al, 2012). We previously reported that repeated daily injections of racemic MDMA (10.0 mg/kg, IP × 5 days) increased the number of ambulatory counts in response to 10.0 mg/kg MDMA and shifted the dose-effect curve for this response to the left when measured 2 days following the last experimenter-administered exposure to MDMA (Bradbury et al, 2012).…”
Section: Discussioncontrasting
confidence: 79%
“…Effects of ±MDMA on vertical activity are equivocal. Some studies have failed to consistently observe this behaviour (O'Loinsigh et al, 2001) whereas others have reported MDMA-produced rearing (Lettfuss et al, 2013).…”
Section: Introductionmentioning
confidence: 97%
“…An increase in vertical locomotor activity was, however, evident in both groups that received MDMA exposure. This finding is consistent with findings from previous studies that also found an increase in vertical locomotor activity following repeated experimenter-administered (Lettfuss et al, 2013), or self-administered (Schenk & Bradbury, 2015) MDMA. Because increased vertical locomotor activity has been attributed to increased DA release (Thiel et al, 1999), an increase in vertical locomotor activity following repeated MDMA exposure may reflect the increase in MDMA-produced DA release produced following pre-exposure (Colussi-Mas et al, 2010;Kalivas et al, 1998).…”
Section: Discussionsupporting
confidence: 92%
“…There are a number of studies that report a sensitised locomotor response following repeated exposure to various stimulants including cocaine (Kalivas & Stewart, 1991;Post & Contel, 1983), and amphetamine (Kuczenski & Segal, 1988;Robinson & Becker, 1986). Repeated administration of MDMA also produced sensitisation of MDMA-produced forward locomotor activity (Ball, Wellman, Fortenberry, & Rebec, 2009;Bradbury, Gittings, & Schenk, 2012;Colussi-Mas & Schenk, 2008;Kalivas, Duffy, & White, 1998;Spanos & Yamamoto, 1989) and vertical locomotor activity (Lettfuss, Seeger-Armbruster, & von Ameln-Mayerhofer, 2013;Schenk & Bradbury, 2015).…”
Section: Behavioural Correlates Of Sensitisationmentioning
confidence: 99%
“…A wealth of data has subsequently shown similar effects following administration of DA agonists, and these effects are blocked by neurotoxic 6-OHDA lesions in the mesolimbic DA system (for example, Kelly & Iversen, 1976) and by DA antagonists (Pijnenburg et al, 1976;Pijnenburg, Honig, & Van Rossum, 1975). Repeated exposure to MDMA (Ball, Budreau, & Rebec, 2006;Ball, Klein, Plocinski, & Slack, 2011;Ball, Wellman, Fortenberry, & Rebec, 2009;Ball, Wellman, Miller, & Rebec, 2010;Bradbury, Gittings, & Schenk, 2012;Colussi-Mas & Schenk, 2008;Kalivas et al, 1998;Lettfuss, Seeger-Armbruster, & von Ameln-Mayerhofer, 2013;Ludwig, Mihov, & Schwarting, 2008;McCreary, Bankson, & Cunningham, 1999;Modi, Yang, Swann, & Dafny, 2006), produced an augmented horizontal activity response following some dosing regimens, corresponding with an enhanced DA response (Kalivas et al, 1993;Kalivas & Stewart, 1991;Sorg & Kalivas, 1991). Enhanced synaptic DA also underlies increased vertical activity (rearing), although relatively fewer investigations of the neurochemical underpinnings of this behaviour have been conducted.…”
Section: Introductionmentioning
confidence: 99%